SecBot SecBot
SECBOTREPLAY Home › Report › CDNA

CDNA · CareDx (CDNA) CEO John Hanna and Director Hannah Valantine sold a…

CareDx, Inc. · CLUSTER filed Jul 16, 2026 at 20:00 ET

At the news

NEUTRALIMPACT 4/10

CLUSTER filed Jul 16, 2026 at 20:00 ET

CareDx (CDNA) CEO John Hanna and Director Hannah Valantine sold a combined ~$5.5M in open-market shares on July 16, 2026, following option exercises. The total sales represent 0.26% of the $2.1B market cap, a modest amount that is not unusual for post-vesting diversification. Insider sales are weak predictors of future returns, and the dollar value relative to company size does not signal material deterioration.

  • CEO John Hanna sold 118,000 shares open-market for ~$4.46M at $36.11–$39.01 per share.
  • Director Hannah Valantine sold 28,779 shares open-market for ~$1.04M at $36.14–$36.55.
  • Total insider sales of ~$5.5M equal 0.26% of the $2.1B market cap.
  • Both insiders exercised options immediately before selling, consistent with routine tax/vesting-related transactions.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access